Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

BACKGROUND: (18)F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic breast and axillary response at various time points dur...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Imaging
Главные авторы: van Ramshorst, Mette S., Teixeira, Suzana C., Koolen, Bas B., Pengel, Kenneth E., Gilhuijs, Kenneth G., Wesseling, Jelle, Rodenhuis, Sjoerd, Valdés Olmos, Renato A., Rutgers, Emiel J., Vogel, Wouter V., Sonke, Gabe S., Vrancken Peeters, Marie-Jeanne T.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445462/
https://ncbi.nlm.nih.gov/pubmed/28545563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40644-017-0117-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы